Literature DB >> 20636111

Are psychiatric diagnoses of psychosis scientific and useful? The case of schizophrenia.

Jim Van Os1.   

Abstract

BACKGROUND: Insurance systems, scientific journals, professional groups, educational initiatives, regulatory bodies and organisation of services appear to be fixed in 19th century diagnostic metaphors for psychosis, providing natural protection against change. Furthermore, the existence of two separate diagnostic systems in psychiatry, DSM and ICD, produces a bias that is conservative rather than anti-conservative, reducing the probability of non-cosmetic change.
METHODS: A qualitative review of the validity, usefulness and acceptability of the diagnosis of 'schizophrenia', in order to assess possible discrepancies between actual diagnostic practice in mental health services and alternatives dictated by scientific evidence and societal developments.
RESULTS: A 21st century concept of psychotic disorder should refer to an experience that can be understood as a variation of normal human mentation that can be expressed quantitatively. For the purpose of diagnosis, use can be made of scientific evidence of specificity yielding high diagnostic likelihood ratios rather than evidence of weak mean differences yielding low diagnostic likelihood ratios. In the case of psychosis, the evidence appears to favour a syndromal system of classification combining categorical and dimensional representations. The concept of 'salience' has the potential to make the public recognise psychosis as relating to an aspect of human mentation and experience that is universal.
CONCLUSIONS: The debate about alternatives to diagnose expressions of psychosis is often misunderstood as a misguided attempt to change societal stigma. In reality, however, it is about reduction of iatrogenic stigma occasioned by the use of unscientific and mystifying terminology. Scientific and societal developments have largely caught up with diagnostic traditions applied to psychosis phenotypes and although the traditional diagnostic system is deeply ingrained in all aspects of clinical and academic activities, change is possible if professional bodies actively promote a modern system of evidence-based diagnostic practice.

Entities:  

Mesh:

Year:  2010        PMID: 20636111     DOI: 10.3109/09638237.2010.492417

Source DB:  PubMed          Journal:  J Ment Health        ISSN: 0963-8237


  9 in total

1.  Viewing the elephant from 200 feet: reconstructing the schizophrenia syndrome.

Authors:  John A Sweeney
Journal:  Schizophr Res       Date:  2011-02-01       Impact factor: 4.939

Review 2.  Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse.

Authors:  Matcheri S Keshavan; Henry A Nasrallah; Rajiv Tandon
Journal:  Schizophr Res       Date:  2011-02-12       Impact factor: 4.939

3.  Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study.

Authors:  Bagrat Abazyan; Jenifer Dziedzic; Kegang Hua; Sofya Abazyan; Chunxia Yang; Susumu Mori; Mikhail V Pletnikov; Tomas R Guilarte
Journal:  Schizophr Bull       Date:  2013-05-28       Impact factor: 9.306

4.  Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.

Authors:  Pamela DeRosse; George C Nitzburg; Melanie Blair; Anil K Malhotra
Journal:  Schizophr Res       Date:  2017-10-19       Impact factor: 4.939

5.  Differences in views of schizophrenia during medical education: a comparative study of 1st versus 5th-6th year Italian medical students.

Authors:  Lorenza Magliano; John Read; Alessandra Sagliocchi; Melania Patalano; Antonio D'Ambrosio; Nicoletta Oliviero
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-11-02       Impact factor: 4.328

6.  Prospective Long-Term Cohort Study of Subjects With First-Episode Psychosis Examining Eight Major Outcome Domains and Their Predictors: Study Protocol.

Authors:  Victor Peralta; Lucía Moreno-Izco; Elena García de Jalón; Ana M Sánchez-Torres; Lucía Janda; David Peralta; Lourdes Fañanás; Manuel J Cuesta
Journal:  Front Psychiatry       Date:  2021-03-19       Impact factor: 4.157

7.  Evidence that a psychopathology interactome has diagnostic value, predicting clinical needs: an experience sampling study.

Authors:  Jim van Os; Tineke Lataster; Philippe Delespaul; Marieke Wichers; Inez Myin-Germeys
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

8.  Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia.

Authors:  Walter H L Pinaya; Ary Gadelha; Orla M Doyle; Cristiano Noto; André Zugman; Quirino Cordeiro; Andrea P Jackowski; Rodrigo A Bressan; João R Sato
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

9.  Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study.

Authors:  Konstantinos N Fountoulakis; Elena Dragioti; Antonis T Theofilidis; Tobias Wikilund; Xenofon Atmatzidis; Ioannis Nimatoudis; Erik Thys; Martien Wampers; Luchezar Hranov; Trayana Hristova; Daniil Aptalidis; Roumen Milev; Felicia Iftene; Filip Spaniel; Pavel Knytl; Petra Furstova; Tiina From; Henry Karlsson; Maija Walta; Raimo K R Salokangas; Jean-Michel Azorin; Justine Bouniard; Julie Montant; Georg Juckel; Ida S Haussleiter; Athanasios Douzenis; Ioannis Michopoulos; Panagiotis Ferentinos; Nikolaos Smyrnis; Leonidas Mantonakis; Zsófia Nemes; Xenia Gonda; Dora Vajda; Anita Juhasz; Amresh Shrivastava; John Waddington; Maurizio Pompili; Anna Comparelli; Valentina Corigliano; Elmars Rancans; Alvydas Navickas; Jan Hilbig; Laurynas Bukelskis; Lidija Injac Stevovic; Sanja Vodopic; Oluyomi Esan; Oluremi Oladele; Christopher Osunbote; Janusz Κ Rybakowski; Pawel Wojciak; Klaudia Domowicz; Maria Luisa Figueira; Ludgero Linhares; Joana Crawford; Anca-Livia Panfil; Daria Smirnova; Olga Izmailova; Dusica Lecic-Tosevski; Henk Temmingh; Fleur Howells; Julio Bobes; Maria Paz Garcia-Portilla; Leticia García-Alvarez; Gamze Erzin; Hasan Karadağ; Avinash De Sousa; Anuja Bendre; Cyril Hoschl; Cristina Bredicean; Ion Papava; Olivera Vukovic; Bojana Pejuskovic; Vincent Russell; Loukas Athanasiadis; Anastasia Konsta; Dan Stein; Michael Berk; Olivia Dean; Rajiv Tandon; Siegfried Kasper; Marc De Hert
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.